Dietary salt is a public health hazard that requires vigorous attack

Canadian Journal of Cardiology

Volumn 30, Issue 5, 2014, Pages 502-506

  Neal, Bruce ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE CONTROL; DIURETIC THERAPY; ELEVATED BLOOD PRESSURE; HEALTH CARE COST; HEALTH HAZARD; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; PUBLIC HEALTH PROBLEM; SALT INTAKE; STOMACH CANCER;

BLOOD PRESSURE; CHRONIC DISEASE; FOOD HABITS; HUMANS; HYPERTENSION; MORBIDITY; PATIENT EDUCATION AS TOPIC; PRIMARY PREVENTION; PUBLIC HEALTH; SODIUM CHLORIDE, DIETARY; SURVIVAL RATE; WORLD HEALTH;

EID: 84899629697     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.02.005     Document Type: Article

References (52)

1. Eaton B., Konner M. Paleolithic nutrition - a consideration of its nature and current implications. N Engl J Med 1985, 312:283-289.
2. Denton D. The Hunger for Salt: An Anthropological, Physiological and Medical Analysis 1982, Springer-Verlag, Berlin/Heidelberg/New York.
3. Kurlansky M. Salt: A World History 2002, Walker & Co, New York.
4. Oliver W., Cohen E., Neel J. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture. Circulation 1975, 52:146-151.
5. Brown I.J., Tzoulaki I., Candeias V., Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol 2009, 38:791-813.
6. Powles J., Fahimi S., Micha R., et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013, e003733.
7. McCarron D., Geerling J., Kazaks A., Stern J. Can dietary sodium intake be modified by public policy?. Clin J Am Soc Nephrol 2009, 4:1878-1882.
8. McCarron D., Drüeke T., Stricker E. Science trumps politics: urinary sodium data challenge US dietary sodium guideline. Am J Clin Nutr Rev 2010, 92:1005-1006.
9. Weir M., Dzau V. The renin-angiotensin aldosterone system: a specific target for hypertension management. Am J Hypertens 1999, 12:205S-213S.
10. Hofman A., Hazebroek A., Valkenburg H. A randomized trial of sodium intake and blood pressure in newborn infants. JAMA 1983, 250:370-373.
11. Kotchen T., Cowley A., Frohlich E. Salt in health and disease - a delicate balance. N Engl J Med 2013, 368:1229-1237.
12. Yang Q., Liu T., Kuklina E., et al. Sodium and potassium intake and mortality among us adults - prospective data from the third National Health and Nutrition Examination Survey. Arch Intern Med 2011, 171:1183-1191.
13. Gardener H., Rundek T., Wright C., Elkind M., Sacco R. Dietary sodium and risk of stroke in the Northern Manhattan Study. Stroke 2012, 43:1200-1205.
14. Son Y.J., Lee Y., Song E.K. Adherence to a sodium-restricted diet is associated with lower symptom burden and longer cardiac event-free survival in patients with heart failure. J Clin Nurs 2011, 20:3029-3038.
15. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
16. Dong J., Li Y., Yang Z., Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol 2010, 5:240-247.
17. Thomas M.C., Moran J., Forsblom C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
18. O'Donnell M.J., Yusuf S., Mente A., et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
19. Neal B., Land M.A., Woodward M. An update on the salt wars-genuine controversy, poor science, or vested interest?. Curr Hypertens Rep 2013, 15:687-693.
20. Campbell N., Correa-Rotter R., Neal B., Cappuccio F.P. New evidence relating to the health impact of reducing salt intake. Nutr Metab Cardiovasc Dis 2011, 21:617-619.
21. MacMahon S., Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet 2001, 357:455-462.
22. Collins R., MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet 2001, 357:373-380.
23. Campbell N.R., Cappuccio F.P., Tobe S.W. Unnecessary controversy regarding dietary sodium: a lot about a little. Can J Cardiol 2011, 27:404-406.
24. Whelton P.K., Appel L.J., Sacco R.L., et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012, 126:2880-2889.
25. He F., Li J., MacGregor G. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
26. Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectiviely-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
27. Ruppert M., Diehl J., Kolloch R., et al. Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klin Wochenschr 1991, 69(Suppl 25):51-57.
28. DiNicolantonio J, Di Pasquale P, Taylor R, Hackam DG. Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis [retraction in 2013;99:820]. Heart doi: Accessed March 20, 2014. doi:10.1136/heartjnl-2012-302337.
29. Moodie R., Stuckler D., Monteiro C., et al. Profits and pandemics: preventing the harmful influence of the tobacco, alcohol and ultra processed food and drink industries. Lancet 2013, 381:670-679.
30. Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334:885-888.
31. Chang H.Y., Hu Y.W., Yue C.S., et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006, 83:1289-1296.
32. Whelton P.K., Appel L.J., Espeland M.A., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998, 279:839-846.
33. He F.J., MacGregor G.A. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004, CD004937.
34. Cutler J.A., Follmann D., Allender P.S. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997, 65:643S-651S.
35. Department of Health and Human Services and Department of Agriculture Dietary Guidelines Advisory Committee. Adults and sodium: what is the relationship between sodium and blood pressure in adults aged 19 years and older? 2010, U.S. Government Printing Office, Washington, DC.
36. Dickinson H.O., Mason J.M., Nicolson D.J., et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006, 24:215-233.
37. Hooper L., Bartlett C., Davey S.G., Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev 2004, CD003656.
38. Strazzullo P. Compelling evidence for salt-dependence of blood pressure from GENSALT. J Hypertens 2009, 27:22-23.
39. He F.J., MacGregor G.A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011, 378:380-382.
40. Beaglehole R., Bonita R., Horton R., et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447.
41. Lim S., Vos T., Flaxman A., et al. The burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions 1990-2010: a systematic analysis for the Global Burden of Disease Study. Lancet 2013, 380:2224-2226.
42. National Heart Foundation of Australia Guide to the Management of Hypertension 2008 2008, National Heart Foundation of Australia, Melbourne.
43. Rodgers A., Ezzati M., Vander Hoorn S., et al. Distribution of major health risks: findings from the Global Burden of Disease Study. PLoS Med 2004, 1:e27.
44. Ikeda N., Sapienza D., Guerrero R., et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ 2014, 92:10-19.
45. Murray C., Lauer J., Hutubessy R., et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003, 361:717-725.
46. Puska P. The North Karelia Project: nearly 20 years of successful prevention of CVD in Finland. Hygie 1992, 11:33-35.
47. Bibbins-Domingo K., Chertow G.M., Coxson P.G., et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
48. Cobiac L.J., Vos T., Veerman J.L. Cost-effectiveness of interventions to reduce dietary salt intake. Heart 2010, 96:1920-1925.
49. Neal B., Wu Y., Li N. The Effectiveness and Costs of Population Interventions to Reduce Salt Consumption 2007, World Health Organization, Geneva.
50. Bloom D.E., Cafiero E.T., Jané-Llopis E., et al. The Global Economic Burden of Noncommunicable Diseases 2011, World Economic Forum, Geneva.
51. The World Health Organization Scaling Up Action Against Noncommunicable Diseases: How Much Will It Cost? 2011, World Health Organization, Geneva.
52. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.